HealthEquity, Inc. (NASDAQ:HQY) Receives Average “Buy” Rating from Analysts

0

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned a consensus rating of “Buy” by the thirteen analysts who cover the company, reports MarketBeat.com. Two research analysts rated the stock with a hold recommendation and nine gave the company a buy recommendation. The 12-month average price target among brokerages that have updated their coverage on the stock in the past year is $74.00.

A number of research companies have weighed in on HQY recently. Jefferies Financial Group began covering HealthEquity shares in a report on Wednesday, Dec. 1. They set a “buy” rating and a price target of $68.00 for the company. Royal Bank of Canada lowered its price target on HealthEquity shares from $87.00 to $70.00 and set an “outperform” rating for the company in a report released Tuesday, December 7. Barrington Research lowered its price target on HealthEquity shares from $80.00 to $55.00 and set an “outperform” rating for the company in a Tuesday, Dec. 7 report. Deutsche Bank Aktiengesellschaft lowered its price target on HealthEquity shares from $75.00 to $52.00 and set a “buy” rating for the company in a Wednesday, Dec. 8 report. Finally, TheStreet downgraded shares of HealthEquity from a “c” rating to a “d+” rating in a report on Tuesday, December 7.

Shares of HQY opened at $54.78 on Friday. The company has a current ratio of 7.14, a quick ratio of 7.14 and a debt ratio of 0.49. The company’s 50-day moving average is $47.96 and its two-hundred-day moving average is $60.02. HealthEquity has a 12-month low of $36.81 and a 12-month high of $90.65. The company has a market capitalization of $4.58 billion, a P/E ratio of -782.46, a PEG ratio of 3.93 and a beta of 1.05.

(A d)

This technology gives doctors the ability to make massive breakthroughs in the human body… And investors the chance to seize huge opportunities…

HealthEquity (NASDAQ:HQY) last released its quarterly results on Monday, December 6. The company reported EPS of $0.35 for the quarter, matching the consensus estimate of $0.35. HealthEquity had a negative net margin of 0.82% and a positive return on equity of 4.60%. The company posted revenue of $180.00 million for the quarter, versus analyst estimates of $185.44 million. In the same period of the previous year, the company had earned earnings per share of $0.30. The company’s quarterly revenue increased 0.3% year over year. Analysts predict that HealthEquity will post EPS of 0.82 for the current year.

In other HealthEquity news, Vice President Angelique Christine Hill sold 6,297 shares of the company in a transaction that took place on Friday, December 10. The shares were sold at an average price of $41.10, for a total transaction of $258,806.70. The sale was disclosed in a filing with the SEC, which is available via the SEC website. Also, director Stuart B. Parker bought 25,000 shares of the company in a transaction on Thursday, December 9. The shares were purchased at an average price of $42.82 per share, for a total transaction of $1,070,500.00. Disclosure of this purchase can be found here. 2.80% of the shares are held by insiders.

A number of institutional investors have recently changed their positions in HQY. Stephens Inc. AR increased its holdings of HealthEquity shares by 11.2% during the second quarter. Stephens Inc. AR now owns 2,200 shares of the company worth $177,000 after buying 222 more shares in the last quarter. Advisory Services Network LLC acquired a new position in HealthEquity in the second quarter worth approximately $233,000. Dimensional Fund Advisors LP increased its stake in HealthEquity by 67.6% in the second quarter. Dimensional Fund Advisors LP now owns 427,636 shares of the company valued at $34,423,000 after purchasing an additional 172,492 shares last quarter. ProShare Advisors LLC increased its stake in HealthEquity by 3.7% in the second quarter. ProShare Advisors LLC now owns 30,537 shares of the company valued at $2,458,000 after purchasing an additional 1,099 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its stake in HealthEquity by 9.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 1,070,074 shares of the company valued at $86,120,000 after purchasing an additional 88,543 shares last quarter. 95.88% of the shares are held by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc. offers a range of solutions for managing healthcare accounts. The company offers its solutions to employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products such as Health Savings and Spending Platform, Health Savings Accounts, Investment Advisory Services, Reimbursement Terms and Healthcare Incentives.

Read more

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in HealthEquity right now?

Before you consider HealthEquity, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market goes viral…and HealthEquity wasn’t on the list.

Although HealthEquity currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Share.

About Author

Comments are closed.